Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (116)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Schneeweiss, S.
Right arrow Articles by Glynn, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schneeweiss, S.
Right arrow Articles by Glynn, R. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 154, No. 9 : 854-864
Copyright © 2001 by The Johns Hopkins University School of Hygiene and Public Health


PRACTICE OF EPIDEMIOLOGY

Performance of Comorbidity Scores to Control for Confounding in Epidemiologic Studies using Claims Data

Sebastian Schneeweiss1,2, John D. Seeger2, Malcolm Maclure2,3, Philip S. Wang1,2, Jerry Avorn1 and Robert J. Glynn1,4

1 Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
2 Department of Epidemiology, Harvard School of Public Health, Boston, MA.
3 Pharmacare, Ministry of Health, British Columbia, Canada.
4 Department of Preventive Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

Comorbidity is an important confounder in epidemiologic studies. The authors compared the predictive performance of comorbidity scores for use in epidemiologic research with administrative databases. Study participants were British Columbia, Canada, residents aged >=65 years who received angiotensin-converting enzyme inhibitors or calcium channel blockers at least once during the observation period. Six scores were computed for all 141,161 participants during the baseline year (1995–1996). Endpoints were death and health care utilization during a 12-month follow-up (1996–1997). Performance was measured by using the c statistic ranging from 0.5 for chance prediction of outcome to 1.0 for perfect prediction. In logistic regression models controlling for age and gender, four scores based on the International Classification of Diseases, Ninth Revision (ICD-9) generally performed better at predicting 1-year mortality (c = 0.771, c = 0.768, c = 0.745, c = 0.745) than medication-based Chronic Disease Score (CDS)-1 and CDS-2 (c = 0.738, c = 0.718). Number of distinct medications used was the best predictor of future physician visits (R2 = 0.121) and expenditures (R2 = 0.128) and a good predictor of mortality (c = 0.745). Combining ICD-9 and medication-based scores improved the c statistics (1.7% and 6.2%, respectively) for predicting mortality. Generalizability of results may be limited to an elderly, predominantly White population with equal access to state-funded health care.

comorbidity; confounding factors (epidemiology); databases; epidemiologic studies; health services

Abbreviations: CDS, Chronic Disease Score; ICD-9, International Classification of Diseases, Ninth Revision; OR, odds ratio; RR, relative risk; SD, standard deviation


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
JCOHome page
M. Miller, H. Mogun, D. Azrael, K. Hempstead, and D. H. Solomon
Cancer and the Risk of Suicide in Older Americans
J. Clin. Oncol., October 10, 2008; 26(29): 4720 - 4724.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. Tang, J. Y. Wan, and J. E. Bailey
Performance of Comorbidity Measures to Predict Stroke and Death in a Community-Dwelling, Hypertensive Medicaid Population
Stroke, July 1, 2008; 39(7): 1938 - 1944.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. S. Adams, C. M. Trinacty, F. Zhang, K. Kleinman, R. W. Grant, J. B. Meigs, S. B. Soumerai, and D. Ross-Degnan
Medication Adherence and Racial Differences in A1C Control
Diabetes Care, May 1, 2008; 31(5): 916 - 921.
[Abstract] [Full Text] [PDF]


Home page
Health Aff (Millwood)Home page
S. B. Soumerai, F. Zhang, D. Ross-Degnan, D. E. Ball, R. F. LeCates, M. R. Law, T. E. Hughes, D. Chapman, and A. S. Adams
Use Of Atypical Antipsychotic Drugs For Schizophrenia In Maine Medicaid Following A Policy Change
Health Aff., May 1, 2008; 27(3): w185 - w195.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
J. L. Rudolph, M. J. Salow, M. C. Angelini, and R. E. McGlinchey
The Anticholinergic Risk Scale and Anticholinergic Adverse Effects in Older Persons
Arch Intern Med, March 10, 2008; 168(5): 508 - 513.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
E. M. Mortensen, M. J. Pugh, L. A. Copeland, M. I. Restrepo, J. E. Cornell, A. Anzueto, and J. A. Pugh
Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia
Eur. Respir. J., March 1, 2008; 31(3): 611 - 617.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
L. L. Lipscombe, T. Gomes, L. E. Levesque, J. E. Hux, D. N. Juurlink, and D. A. Alter
Thiazolidinediones and Cardiovascular Outcomes in Older Patients With Diabetes
JAMA, December 12, 2007; 298(22): 2634 - 2643.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
J. Hollis, D. Grayson, L. Forrester, H. Brodaty, S. Touyz, and R. Cumming
Antipsychotic Medication Dispensing and Risk of Death in Veterans and War Widows 65 Years and Older
Am J Geriatr Psychiatry, November 1, 2007; 15(11): 932 - 941.
[Abstract] [Full Text] [PDF]


Home page
Health Aff (Millwood)Home page
Y. Zhang and S. B. Soumerai
Do Newer Prescription Drugs Pay For Themselves? A Reassessment Of The Evidence
Health Aff., May 1, 2007; 26(3): 880 - 886.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
J. F. Wharam, B. E. Landon, A. A. Galbraith, K. P. Kleinman, S. B. Soumerai, and D. Ross-Degnan
Emergency Department Use and Subsequent Hospitalizations Among Members of a High-Deductible Health Plan
JAMA, March 14, 2007; 297(10): 1093 - 1102.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
S. Schneeweiss, S. Setoguchi, A. Brookhart, C. Dormuth, and P. S. Wang
Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients
Can. Med. Assoc. J., February 27, 2007; 176(5): 627 - 632.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
J M Brophy, L E Levesque, and B Zhang
The coronary risk of cyclo-oxygenase-2 inhibitors in patients with a previous myocardial infarction
Heart, February 1, 2007; 93(2): 189 - 194.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
C. M. Bell, J. Bajcar, A. S. Bierman, P. Li, M. M. Mamdani, and D. R. Urbach
Potentially Unintended Discontinuation of Long-term Medication Use After Elective Surgical Procedures
Arch Intern Med, December 11, 2006; 166(22): 2525 - 2531.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
V. Schneider, L. E. Levesque, B. Zhang, T. Hutchinson, and J. M. Brophy
Association of Selective and Conventional Nonsteroidal Antiinflammatory Drugs with Acute Renal Failure: A Population-based, Nested Case-Control Analysis
Am. J. Epidemiol., November 1, 2006; 164(9): 881 - 889.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
I. A. Dhalla, M. M. Mamdani, A. E. Simor, A. Kopp, P. A. Rochon, and D. N. Juurlink
Are Broad-Spectrum Fluoroquinolones More Likely To Cause Clostridium difficile-Associated Disease?
Antimicrob. Agents Chemother., September 1, 2006; 50(9): 3216 - 3219.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
D. A. Alter, D. T. Ko, A. Newman, and J. V. Tu
Factors explaining the under-use of reperfusion therapy among ideal patients with ST-segment elevation myocardial infarction
Eur. Heart J., July 1, 2006; 27(13): 1539 - 1549.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
L. E. Levesque, J. M. Brophy, and B. Zhang
Time variations in the risk of myocardial infarction among elderly users of COX-2 inhibitors
Can. Med. Assoc. J., May 23, 2006; 174(11): 1563 - 1569.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
D. N. Juurlink, M. M. Mamdani, A. Kopp, and D. A. Redelmeier
The Risk of Suicide With Selective Serotonin Reuptake Inhibitors in the Elderly
Am J Psychiatry, May 1, 2006; 163(5): 813 - 821.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
J. George, T. Vuong, M. J Bailey, D. C. Kong, J. L Marriott, and K. Stewart
Development and Validation of the Medication-Based Disease Burden Index
Ann. Pharmacother., April 1, 2006; 40(4): 645 - 650.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
L. Y. Park-Wyllie, D. N. Juurlink, A. Kopp, B. R. Shah, T. A. Stukel, C. Stumpo, L. Dresser, D. E. Low, and M. M. Mamdani
Outpatient Gatifloxacin Therapy and Dysglycemia in Older Adults
N. Engl. J. Med., March 30, 2006; 354(13): 1352 - 1361.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
P. S. Wang, S. Schneeweiss, J. Avorn, M. A. Fischer, H. Mogun, D. H. Solomon, and M. A. Brookhart
Risk of death in elderly users of conventional vs. atypical antipsychotic medications.
N. Engl. J. Med., December 1, 2005; 353(22): 2335 - 2341.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. S. Adams, F. Zhang, C. Mah, R. W. Grant, K. Kleinman, J. B. Meigs, and D. Ross-Degnan
Race Differences in Long-Term Diabetes Management in an HMO
Diabetes Care, December 1, 2005; 28(12): 2844 - 2849.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
N. R. Benazon, M. M. Mamdani, and J. C. Coyne
Trends in the Prescribing of Antidepressants Following Acute Myocardial Infarction, 1993-2002
Psychosom Med, November 1, 2005; 67(6): 916 - 920.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
J. Pepin, L. Valiquette, and B. Cossette
Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec
Can. Med. Assoc. J., October 25, 2005; 173(9): 1037 - 1042.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
P. A. Rochon, T. A. Stukel, K. Sykora, S. Gill, S. Garfinkel, G. M. Anderson, S.-L. T. Normand, M. Mamdani, P. E. Lee, P. Li, et al.
Atypical Antipsychotics and Parkinsonism
Arch Intern Med, September 12, 2005; 165(16): 1882 - 1888.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
D. R. Globe, R. Varma, M. Torres, J. Wu, R. Klein, S. P. Azen, and for the Los Angeles Latino Eye Study Group
Self-reported Comorbidities and Visual Function in a Population-Based Study: The Los Angeles Latino Eye Study
Arch Ophthalmol, June 1, 2005; 123(6): 815 - 821.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. G. Hackam, A. Kopp, and D. A. Redelmeier
Prognostic Implications of Warfarin Cessation After Major Trauma: A Population-Based Cohort Analysis
Circulation, May 3, 2005; 111(17): 2250 - 2256.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
T. Sturmer, S. Schneeweiss, M. A. Brookhart, K. J. Rothman, J. Avorn, and R. J. Glynn
Analytic Strategies to Adjust Confounding using Exposure Propensity Scores and Disease Risk Scores: Nonsteroidal Antiinflammatory Drugs and Short-term Mortality in the Elderly
Am. J. Epidemiol., May 1, 2005; 161(9): 891 - 898.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
S. S. Gill, M. Mamdani, G. Naglie, D. L. Streiner, S. E. Bronskill, A. Kopp, K. I. Shulman, P. E. Lee, and P. A. Rochon
A Prescribing Cascade Involving Cholinesterase Inhibitors and Anticholinergic Drugs
Arch Intern Med, April 11, 2005; 165(7): 808 - 813.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
K. I. Shulman, K. Sykora, S. S. Gill, M. Mamdani, G. Anderson, C. Marras, W. P. Wodchis, P. E. Lee, and P. Rochon
New Thyroxine Treatment in Older Adults Beginning Lithium Therapy: Implications for Clinical Practice
Am J Geriatr Psychiatry, April 1, 2005; 13(4): 299 - 304.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
B. R. Shah, J. E. Hux, A. Laupacis, B. Zinman, and C. van Walraven
Clinical Inertia in Response to Inadequate Glycemic Control: Do specialists differ from primary care physicians?
Diabetes Care, March 1, 2005; 28(3): 600 - 606.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
J. C. McGregor, P. W. Kim, E. N. Perencevich, D. D. Bradham, J. P. Furuno, K. S. Kaye, J. C. Fink, P. Langenberg, M.-C. Roghmann, and A. D. Harris
Utility of the Chronic Disease Score and Charlson Comorbidity Index as Comorbidity Measures for Use in Epidemiologic Studies of Antibiotic-resistant Organisms
Am. J. Epidemiol., March 1, 2005; 161(5): 483 - 493.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
S. S Gill, P. A Rochon, N. Herrmann, P. E Lee, K. Sykora, N. Gunraj, S.-L. T Normand, J. H Gurwitz, C. Marras, W. P Wodchis, et al.
Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study
BMJ, February 26, 2005; 330(7489): 445.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
L. E. Levesque, J. M. Brophy, and B. Zhang
The Risk for Myocardial Infarction with Cyclooxygenase-2 Inhibitors: A Population Study of Elderly Adults
Ann Intern Med, February 8, 2005; (2005) 0000605-200504050-00113.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. Battistella, M. M. Mamdami, D. N. Juurlink, L. Rabeneck, and A. Laupacis
Risk of Upper Gastrointestinal Hemorrhage in Warfarin Users Treated With Nonselective NSAIDs or COX-2 Inhibitors
Arch Intern Med, January 24, 2005; 165(2): 189 - 192.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
R. Padwal, M. Mamdani, D. A. Alter, J. E. Hux, D. M. Rothwell, K. Tu, and A. Laupacis
Antihypertensive Therapy and Incidence of Type 2 Diabetes in an Elderly Cohort
Diabetes Care, October 1, 2004; 27(10): 2458 - 2463.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
S. J Shalansky, A. R Levy, and A. P Ignaszewski
Self-Reported Morisky Score for Identifying Nonadherence with Cardiovascular Medications
Ann. Pharmacother., September 1, 2004; 38(9): 1363 - 1368.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
N. Herrmann, M. Mamdani, and K. L. Lanctot
Atypical Antipsychotics and Risk of Cerebrovascular Accidents
Am J Psychiatry, June 1, 2004; 161(6): 1113 - 1115.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
D. T. Ko, M. Mamdani, and D. A. Alter
Lipid-Lowering Therapy With Statins in High-Risk Elderly Patients: The Treatment-Risk Paradox
JAMA, April 21, 2004; 291(15): 1864 - 1870.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
D. N. Juurlink, M. Mamdani, A. Kopp, A. Laupacis, and D. A. Redelmeier
Drug-Drug Interactions Among Elderly Patients Hospitalized for Drug Toxicity
JAMA, April 2, 2003; 289(13): 1652 - 1658.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. Mamdani, P. Rochon, D. N. Juurlink, G. M. Anderson, A. Kopp, G. Naglie, P. C. Austin, and A. Laupacis
Effect of Selective Cyclooxygenase 2 Inhibitors and Naproxen on Short-term Risk of Acute Myocardial Infarction in the Elderly
Arch Intern Med, February 24, 2003; 163(4): 481 - 486.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
M. Mamdani, P. A Rochon, D. N Juurlink, A. Kopp, G. M Anderson, G. Naglie, P. C Austin, and A. Laupacis
Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs
BMJ, September 21, 2002; 325(7365): 624 - 624.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. Schneeweiss, A. M. Walker, R. J. Glynn, M. Maclure, C. Dormuth, and S. B. Soumerai
Outcomes of Reference Pricing for Angiotensin-Converting-Enzyme Inhibitors
N. Engl. J. Med., March 14, 2002; 346(11): 822 - 829.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
L. E. Levesque, J. M. Brophy, and B. Zhang
The Risk for Myocardial Infarction with Cyclooxygenase-2 Inhibitors: A Population Study of Elderly Adults
Ann Intern Med, April 5, 2005; 142(7): 481 - 489.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.